Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens
; 34(7): 1347-56, 2016 07.
Article
in En
| MEDLINE
| ID: mdl-27065001
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parathyroid Hormone
/
Spironolactone
/
Blood Pressure
/
Mineralocorticoid Receptor Antagonists
/
Hyperparathyroidism, Primary
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Hypertens
Year:
2016
Document type:
Article